 | • レポートコード：QYR2104Z4202 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、核酸ベース治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アンチセンス＆抗遺伝子、抑制短配列、遺伝子導入療法、ヌクレオシド類似体、リボザイム、アプタマー）、用途別市場規模（病院、学術研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・核酸ベース治療薬の市場動向 ・企業の競争状況、市場シェア ・核酸ベース治療薬の種類別市場規模（アンチセンス＆抗遺伝子、抑制短配列、遺伝子導入療法、ヌクレオシド類似体、リボザイム、アプタマー） ・核酸ベース治療薬の用途別市場規模（病院、学術研究機関） ・核酸ベース治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・核酸ベース治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・核酸ベース治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・核酸ベース治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・核酸ベース治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Wave Life Sciences、Imugene、Caperna、Phylogica、Protagonist Therapeutics、Benitec Biopharma、EGEN、BioMedica、Transgene、Copernicus Therapeutics） ・結論 |
Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.
Although most of the nucleic acid-based drugs are in early stages of clinical trials, these classes of compounds have emerged in recent years to yield extremely promising candidates for drug therapy to a wide range of diseases, including cancer, infectious diseases, diabetes, cardiovascular, inflammatory, and neurodegenerative diseases, cystic fibrosis, hemophilia, and other genetic disorders.
Market Analysis and Insights: Global Nucleic Acid-based Therapeutics Market
The global Nucleic Acid-based Therapeutics market size is projected to reach US$ 679 million by 2026, from US$ 519.4 million in 2019, at a CAGR of 3.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nucleic Acid-based Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nucleic Acid-based Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nucleic Acid-based Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nucleic Acid-based Therapeutics market.
Global Nucleic Acid-based Therapeutics Scope and Market Size
Nucleic Acid-based Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nucleic Acid-based Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Anti-Sense And Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Segment by Application
Hospitals
Academic & Research Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Wave Life Sciences
Imugene
Caperna
Phylogica
Protagonist Therapeutics
Benitec Biopharma
EGEN
BioMedica
Transgene
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-Sense And Anti-Gene
1.2.3 Short Inhibitory Sequences
1.2.4 Gene Transfer Therapy
1.2.5 Nucleoside Analogs
1.2.6 Ribozymes
1.2.7 Aptamers
1.3 Market by Application
1.3.1 Global Nucleic Acid-based Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Academic & Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid-based Therapeutics Market Perspective (2016-2027)
2.2 Nucleic Acid-based Therapeutics Growth Trends by Regions
2.2.1 Nucleic Acid-based Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nucleic Acid-based Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Nucleic Acid-based Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Nucleic Acid-based Therapeutics Industry Dynamic
2.3.1 Nucleic Acid-based Therapeutics Market Trends
2.3.2 Nucleic Acid-based Therapeutics Market Drivers
2.3.3 Nucleic Acid-based Therapeutics Market Challenges
2.3.4 Nucleic Acid-based Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid-based Therapeutics Players by Revenue
3.1.1 Global Top Nucleic Acid-based Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Nucleic Acid-based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid-based Therapeutics Revenue
3.4 Global Nucleic Acid-based Therapeutics Market Concentration Ratio
3.4.1 Global Nucleic Acid-based Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid-based Therapeutics Revenue in 2020
3.5 Nucleic Acid-based Therapeutics Key Players Head office and Area Served
3.6 Key Players Nucleic Acid-based Therapeutics Product Solution and Service
3.7 Date of Enter into Nucleic Acid-based Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid-based Therapeutics Breakdown Data by Type
4.1 Global Nucleic Acid-based Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Nucleic Acid-based Therapeutics Forecasted Market Size by Type (2022-2027)
5 Nucleic Acid-based Therapeutics Breakdown Data by Application
5.1 Global Nucleic Acid-based Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Nucleic Acid-based Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nucleic Acid-based Therapeutics Market Size (2016-2027)
6.2 North America Nucleic Acid-based Therapeutics Market Size by Type
6.2.1 North America Nucleic Acid-based Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Nucleic Acid-based Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Nucleic Acid-based Therapeutics Market Size by Type (2016-2027)
6.3 North America Nucleic Acid-based Therapeutics Market Size by Application
6.3.1 North America Nucleic Acid-based Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Nucleic Acid-based Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Nucleic Acid-based Therapeutics Market Size by Application (2016-2027)
6.4 North America Nucleic Acid-based Therapeutics Market Size by Country
6.4.1 North America Nucleic Acid-based Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Nucleic Acid-based Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Nucleic Acid-based Therapeutics Market Size (2016-2027)
7.2 Europe Nucleic Acid-based Therapeutics Market Size by Type
7.2.1 Europe Nucleic Acid-based Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Nucleic Acid-based Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Nucleic Acid-based Therapeutics Market Size by Type (2016-2027)
7.3 Europe Nucleic Acid-based Therapeutics Market Size by Application
7.3.1 Europe Nucleic Acid-based Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Nucleic Acid-based Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Nucleic Acid-based Therapeutics Market Size by Application (2016-2027)
7.4 Europe Nucleic Acid-based Therapeutics Market Size by Country
7.4.1 Europe Nucleic Acid-based Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Nucleic Acid-based Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid-based Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Type
8.2.1 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Application
8.3.1 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Region
8.4.1 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nucleic Acid-based Therapeutics Market Size (2016-2027)
9.2 Latin America Nucleic Acid-based Therapeutics Market Size by Type
9.2.1 Latin America Nucleic Acid-based Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Nucleic Acid-based Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Nucleic Acid-based Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Nucleic Acid-based Therapeutics Market Size by Application
9.3.1 Latin America Nucleic Acid-based Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Nucleic Acid-based Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Nucleic Acid-based Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Nucleic Acid-based Therapeutics Market Size by Country
9.4.1 Latin America Nucleic Acid-based Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Nucleic Acid-based Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid-based Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type
10.2.1 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application
10.3.1 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Country
10.4.1 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Details
11.1.2 Wave Life Sciences Business Overview
11.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Introduction
11.1.4 Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2016-2021)
11.1.5 Wave Life Sciences Recent Development
11.2 Imugene
11.2.1 Imugene Company Details
11.2.2 Imugene Business Overview
11.2.3 Imugene Nucleic Acid-based Therapeutics Introduction
11.2.4 Imugene Revenue in Nucleic Acid-based Therapeutics Business (2016-2021)
11.2.5 Imugene Recent Development
11.3 Caperna
11.3.1 Caperna Company Details
11.3.2 Caperna Business Overview
11.3.3 Caperna Nucleic Acid-based Therapeutics Introduction
11.3.4 Caperna Revenue in Nucleic Acid-based Therapeutics Business (2016-2021)
11.3.5 Caperna Recent Development
11.4 Phylogica
11.4.1 Phylogica Company Details
11.4.2 Phylogica Business Overview
11.4.3 Phylogica Nucleic Acid-based Therapeutics Introduction
11.4.4 Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2016-2021)
11.4.5 Phylogica Recent Development
11.5 Protagonist Therapeutics
11.5.1 Protagonist Therapeutics Company Details
11.5.2 Protagonist Therapeutics Business Overview
11.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Introduction
11.5.4 Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2016-2021)
11.5.5 Protagonist Therapeutics Recent Development
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Company Details
11.6.2 Benitec Biopharma Business Overview
11.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Introduction
11.6.4 Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2016-2021)
11.6.5 Benitec Biopharma Recent Development
11.7 EGEN
11.7.1 EGEN Company Details
11.7.2 EGEN Business Overview
11.7.3 EGEN Nucleic Acid-based Therapeutics Introduction
11.7.4 EGEN Revenue in Nucleic Acid-based Therapeutics Business (2016-2021)
11.7.5 EGEN Recent Development
11.8 BioMedica
11.8.1 BioMedica Company Details
11.8.2 BioMedica Business Overview
11.8.3 BioMedica Nucleic Acid-based Therapeutics Introduction
11.8.4 BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2016-2021)
11.8.5 BioMedica Recent Development
11.9 Transgene
11.9.1 Transgene Company Details
11.9.2 Transgene Business Overview
11.9.3 Transgene Nucleic Acid-based Therapeutics Introduction
11.9.4 Transgene Revenue in Nucleic Acid-based Therapeutics Business (2016-2021)
11.9.5 Transgene Recent Development
11.10 Copernicus Therapeutics
11.10.1 Copernicus Therapeutics Company Details
11.10.2 Copernicus Therapeutics Business Overview
11.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Introduction
11.10.4 Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2016-2021)
11.10.5 Copernicus Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-Sense And Anti-Gene
Table 3. Key Players of Short Inhibitory Sequences
Table 4. Key Players of Gene Transfer Therapy
Table 5. Key Players of Nucleoside Analogs
Table 6. Key Players of Ribozymes
Table 7. Key Players of Aptamers
Table 8. Global Nucleic Acid-based Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Nucleic Acid-based Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Nucleic Acid-based Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Nucleic Acid-based Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Nucleic Acid-based Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Nucleic Acid-based Therapeutics Market Share by Regions (2022-2027)
Table 14. Nucleic Acid-based Therapeutics Market Trends
Table 15. Nucleic Acid-based Therapeutics Market Drivers
Table 16. Nucleic Acid-based Therapeutics Market Challenges
Table 17. Nucleic Acid-based Therapeutics Market Restraints
Table 18. Global Nucleic Acid-based Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Nucleic Acid-based Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Nucleic Acid-based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nucleic Acid-based Therapeutics as of 2020)
Table 21. Ranking of Global Top Nucleic Acid-based Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Nucleic Acid-based Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Nucleic Acid-based Therapeutics Product Solution and Service
Table 25. Date of Enter into Nucleic Acid-based Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nucleic Acid-based Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Nucleic Acid-based Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Nucleic Acid-based Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Nucleic Acid-based Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Nucleic Acid-based Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Nucleic Acid-based Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Nucleic Acid-based Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Nucleic Acid-based Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Nucleic Acid-based Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Nucleic Acid-based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Nucleic Acid-based Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Nucleic Acid-based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Nucleic Acid-based Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Nucleic Acid-based Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Nucleic Acid-based Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Nucleic Acid-based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Nucleic Acid-based Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Nucleic Acid-based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Nucleic Acid-based Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Nucleic Acid-based Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Nucleic Acid-based Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Nucleic Acid-based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Nucleic Acid-based Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Nucleic Acid-based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Nucleic Acid-based Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Nucleic Acid-based Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Wave Life Sciences Company Details
Table 66. Wave Life Sciences Business Overview
Table 67. Wave Life Sciences Nucleic Acid-based Therapeutics Product
Table 68. Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Wave Life Sciences Recent Development
Table 70. Imugene Company Details
Table 71. Imugene Business Overview
Table 72. Imugene Nucleic Acid-based Therapeutics Product
Table 73. Imugene Revenue in Nucleic Acid-based Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Imugene Recent Development
Table 75. Caperna Company Details
Table 76. Caperna Business Overview
Table 77. Caperna Nucleic Acid-based Therapeutics Product
Table 78. Caperna Revenue in Nucleic Acid-based Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Caperna Recent Development
Table 80. Phylogica Company Details
Table 81. Phylogica Business Overview
Table 82. Phylogica Nucleic Acid-based Therapeutics Product
Table 83. Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Phylogica Recent Development
Table 85. Protagonist Therapeutics Company Details
Table 86. Protagonist Therapeutics Business Overview
Table 87. Protagonist Therapeutics Nucleic Acid-based Therapeutics Product
Table 88. Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Protagonist Therapeutics Recent Development
Table 90. Benitec Biopharma Company Details
Table 91. Benitec Biopharma Business Overview
Table 92. Benitec Biopharma Nucleic Acid-based Therapeutics Product
Table 93. Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Benitec Biopharma Recent Development
Table 95. EGEN Company Details
Table 96. EGEN Business Overview
Table 97. EGEN Nucleic Acid-based Therapeutics Product
Table 98. EGEN Revenue in Nucleic Acid-based Therapeutics Business (2016-2021) & (US$ Million)
Table 99. EGEN Recent Development
Table 100. BioMedica Company Details
Table 101. BioMedica Business Overview
Table 102. BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2016-2021) & (US$ Million)
Table 103. BioMedica Recent Development
Table 104. Transgene Company Details
Table 105. Transgene Business Overview
Table 106. Transgene Nucleic Acid-based Therapeutics Product
Table 107. Transgene Revenue in Nucleic Acid-based Therapeutics Business (2016-2021) & (US$ Million)
Table 108. Transgene Recent Development
Table 109. Copernicus Therapeutics Company Details
Table 110. Copernicus Therapeutics Business Overview
Table 111. Copernicus Therapeutics Nucleic Acid-based Therapeutics Product
Table 112. Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2016-2021) & (US$ Million)
Table 113. Copernicus Therapeutics Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid-based Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Anti-Sense And Anti-Gene Features
Figure 3. Short Inhibitory Sequences Features
Figure 4. Gene Transfer Therapy Features
Figure 5. Nucleoside Analogs Features
Figure 6. Ribozymes Features
Figure 7. Aptamers Features
Figure 8. Global Nucleic Acid-based Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Academic & Research Institutes Case Studies
Figure 11. Nucleic Acid-based Therapeutics Report Years Considered
Figure 12. Global Nucleic Acid-based Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Nucleic Acid-based Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Nucleic Acid-based Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Nucleic Acid-based Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Nucleic Acid-based Therapeutics Market Share by Players in 2020
Figure 17. Global Top Nucleic Acid-based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nucleic Acid-based Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Nucleic Acid-based Therapeutics Revenue in 2020
Figure 19. Global Nucleic Acid-based Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Nucleic Acid-based Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Nucleic Acid-based Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Nucleic Acid-based Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Nucleic Acid-based Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Nucleic Acid-based Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Nucleic Acid-based Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Nucleic Acid-based Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Nucleic Acid-based Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Nucleic Acid-based Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Nucleic Acid-based Therapeutics Market Share by Region (2016-2027)
Figure 41. China Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Nucleic Acid-based Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Nucleic Acid-based Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Nucleic Acid-based Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Nucleic Acid-based Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Nucleic Acid-based Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Nucleic Acid-based Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Nucleic Acid-based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Wave Life Sciences Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2016-2021)
Figure 61. Imugene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2016-2021)
Figure 62. Caperna Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2016-2021)
Figure 63. Phylogica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2016-2021)
Figure 64. Protagonist Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2016-2021)
Figure 65. Benitec Biopharma Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2016-2021)
Figure 66. EGEN Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2016-2021)
Figure 67. BioMedica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2016-2021)
Figure 68. Transgene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2016-2021)
Figure 69. Copernicus Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の核酸ベース診断市場規模・現状・予測（2021年-2027年） Nucleic acid diagnosis is a method of diagnosis of human body state and disease by using the theory and technology of molecular biology to directly investigate the existence state or defect of nucleic acid, analyze the function of nucleic acid from the nucleic acid structure, replication, transcript…- 世界の遺伝子治療薬市場規模・現状・予測（2021年-2027年） Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery Market Analysis and Insights: Global Drugs B…
- 世界の核酸ラベリング市場規模・現状・予測（2021年-2027年） Nucleic acid labeling techniques has wide range of applications in Life sciences industry. Nucleic acid Labeling is mainly used to identify proteins, DNA and RNA by using various Labeling techniques. Based on the product, the market was segmented into reagents and kits and Services. Among them, reag…
- 世界の核酸検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nucleic Acid Testing Market The global Nucleic Acid Testing market size is projected to reach US$ 2730.6 million by 2026, from US$ 1840 million in 2019, at a CAGR of 5.7% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the r…
- 世界の核酸増幅検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nucleic Acid Amplification Testing Market The global Nucleic Acid Amplification Testing market size is projected to reach US$ 177.3 million by 2026, from US$ 131.5 million in 2019, at a CAGR of 4.3% during 2021-2026. With industry-standard accuracy in analysis an…